2002
DOI: 10.1046/j.1365-2362.2002.00994.x
|View full text |Cite
|
Sign up to set email alerts
|

Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier

Abstract: In both HIVE and AD, blood-borne activated monocyte/macrophages and lymphocytes appear to migrate through a disrupted blood-brain barrier. The lacunae around macrophages in amyloid-beta plaques but not in vessel walls are consistent with the ability of macrophages to phagocytize and clear amyloid-beta deposits in vitro.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
205
0
2

Year Published

2007
2007
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 259 publications
(221 citation statements)
references
References 64 publications
6
205
0
2
Order By: Relevance
“…These findings support previous studies demonstrating BBB damage in AD [12][13][14][15][16][17][18][19][20][21][22][23][24][25] and suggest that APOE genotype influences the degree of BBB damage. 15,17,[22][23][24] The present study extends, however, previous findings by showing that a greater BBB disruption in AD APOE4 compared with AD APOE3 carriers could be related at least, in part, to a greater loss of pericyte population that has been shown to lead to a small vessel disease and a chronic BBB breakdown in murine transgenic models [6][7][8][9] and is associated with BBB breakdown in human neurodegenerative disorders such as AD [10][11][12] and amyotrophic lateral sclerosis.…”
Section: Discussionsupporting
confidence: 92%
“…These findings support previous studies demonstrating BBB damage in AD [12][13][14][15][16][17][18][19][20][21][22][23][24][25] and suggest that APOE genotype influences the degree of BBB damage. 15,17,[22][23][24] The present study extends, however, previous findings by showing that a greater BBB disruption in AD APOE4 compared with AD APOE3 carriers could be related at least, in part, to a greater loss of pericyte population that has been shown to lead to a small vessel disease and a chronic BBB breakdown in murine transgenic models [6][7][8][9] and is associated with BBB breakdown in human neurodegenerative disorders such as AD [10][11][12] and amyotrophic lateral sclerosis.…”
Section: Discussionsupporting
confidence: 92%
“…Mediators identified in the inflammatory process include vasoactive amines (histamine and serotonin), eicosanoids (metabolites of arachidonic acid, prostaglandins and leukotrienes), platelet aggregation factors, cytokines (interleukins and tumoral necrosis factor -TNF), kinins (bradykinin), and free oxygen radicals, among others (Czermak et al, 1998;Ohishi, 2000). These substances are produced by inflammatory cells such as polymorphonuclear leukocytes (neutrophils, eosinophils, basophils), endothelial cells, mast cells, macrophages, monocytes, and lymphocytes (Fiala et al, 2002).…”
Section: Chemical Aspects Of the Inflammatory Responsementioning
confidence: 99%
“…Besides, enhanced levels of PGE 2 , the major product of COX-2, have been detected in cerebrospinal fluid in patients with HAD; these enhanced levels were associated with severity of dementia (30). Moreover, COX-2-positive macrophages infiltrating the brain of patients with HIV-1 encephalitis were described (31). There is also increasing evidence that COX-2 is involved in the pathogenesis of other neurological disorders associated with inflammation, including ischemic brain injury or Alzheimer's disease (reviewed in Ref.…”
mentioning
confidence: 99%